Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11268077
Materials and methods for treatment of hemoglobinopathies
granted -
US 11266694
Restimulation of cryopreserved tumor infiltrating lymphocytes
granted -
US 11266692
Intracellular genomic transplant and methods of therapy
granted -
US 11266649
Pharmaceutical formulations
granted -
US 11267832
Mn(II)-based sensors to detect zinc in vivo with MRI
granted -
US 11268154
Methods for the identification, evaluation and treatment of patients having multiple myeloma
granted -
US 11267782
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors
granted -
US 11266746
Therapeutic antitumor combination of a TLR4 ligand with other treatments
granted -
US 11267822
BET bromodomain protein degraders with cleavable linkers
granted -
US 11267859
GM-CSF mimetics and methods of making and using same
granted -
US 11267785
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amides
granted -
US 11266742
Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
granted -
US 11266724
Modified factor VII polypeptides for subcutaneous administration and on-demand treatment
granted -
US 11266720
Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof
granted -
US 11266693
Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
granted -
US 11266699
Synergistic bacterial compositions and methods of production and use thereof
granted -
US 11268096
Compounds for modulating Fc-epsilon-RI-beta expression and uses thereof
granted -
US 11268145
Methods for treating Cushing's syndrome
granted -
US 11266676
MicroRNA in T cell activation
granted -
US 11266661
Vaginal inserted estradiol pharmaceutical compositions and methods
granted -
US 11268098
Non-aggregating immunostimulatory oligonucleotides
granted -
US 11266657
Pharmaceutical compositions comprising meloxicam
granted -
US 11266655
Methods and compositions for treating urea cycle disorders
granted -
US 11266641
Formulations of a somatostatin modulator
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.